AFFINIA THERAPEUTICS
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.
AFFINIA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.affiniatx.com
Total Employee:
51+
Status:
Active
Contact:
617-430-7817
Email Addresses:
[email protected]
Total Funding:
170 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager Nginx Microsoft Exchange Online Office 365 Mail Google Maps
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Advisors List
Current Employees Featured
Founder
Investors List
Woodline Partners
Woodline Partners investment in Series B - Affinia Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Affinia Therapeutics
Octagon Capital Advisors
Octagon Capital Advisors investment in Series B - Affinia Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Affinia Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Series B - Affinia Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Affinia Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Affinia Therapeutics
Lonza
Lonza investment in Series B - Affinia Therapeutics
GV
GV investment in Series B - Affinia Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Affinia Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-14 | Affinia Therapeutics Appoints Thomas Leggett as Chief Financial Officer |
Official Site Inspections
http://www.affiniatx.com Semrush global rank: 5.06 M Semrush visits lastest month: 1.63 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
